0       0

AMDA's 31st Annual Symposium


B27 - Exploring Best Practices in Medical Directors-Consultant Pharmacist Collaboration on the F-329


Mar 7, 2008 3:30pm ‐ Mar 7, 2008 5:00pm

Standard: $20.00

Description

This session explores models for medical director / consultant pharmacist collaboration discussing the implementation, utilization and benefits of a currently practiced collaborative agreement between physicians and consultant pharmacist in the long term care setting. In 2003, the American College of Clinical Pharmacy published a position statement in pharmacotherapy noting programs administered by the USPH, the armed forces and VHA as well as 32 states, support pharmacist participation in collaborative practice. Presenters discuss positive outcomes in patient care, increased regulatory compliance, decreased costs and the influence in practice standards (both for physician and pharmacist).

    Learning Objectives:
  • Explain the currently "functioning" collaborative practice agreement in a skilled nursing facility
  • Recognize the various attributes of various state and federal regulations governing ollaborative practice
  • Assess and analyze current and future opportunities for professional relationships
  • Define roles of each practitioner emphasizing the benefits
  • Assess potential problems and provide solutions regarding the implementation of a collaborative practice agreement

Speaker(s):

You must be logged in and own this session in order to post comments.

Print Certificate
Review Answers
Print Transcript
Completed on: token-completed_on
Review Answers
Please select the appropriate credit type:
/
test_id: 
credits: 
completed on: 
rendered in: 
* - Indicates answer is required.
token-content

token-speaker-name
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
token-index
token-content
/
/
token-index
token-content
token-index
token-content